BioControl develops advanced active implantable medical devices for the treatment of autonomic disorders, conditions whereby the autonomic nervous system ceases to function properly, resulting in a disruption to the control of involuntary body processes. The devices enable controlled electrical stimulation of various nerves to achieve therapeutic results.
BioControl has developed the CardioFit(r) System, intended to effectively treat heart failure via vagus nerve stimulation. It has received the CE mark (2008) and is available in the U.S. under Investigational Device Exemption.
Active implantable devices